BJP-2000-BECH-421-8

In our protocol for this meta analysis we defined the

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: n our protocol for this meta-analysis we defined the criteria for selecting trials, before we accessed the trials database: (a) identical or very similar clinical inclusion criteria for patients (major depression as defined by DSM±III (American Psychiatric Association, 1980); (b) use of the Hamilton Depression Rating Scale (HDRS±17; Hamilton, 1967; and the first 17 items from trials that used more than 17); and (c) a double-blind follow-up phase of at least six weeks. For the non-USA trials, we analysed only trials of fluoxetine v. TCAs since the three non-USA placebo-controlled trials (116 patients) in the database did not satisfy our inclusion criteria or included very few patients. The same inclusion criteria were used for non-USA trials, except that trials with a five-week, double-blind follow-up period were also included since their exclusion would have led to only a handful of trials with a small number of patients being included. The database contained only one USA trial with a fiveweek double-blind follow-up period, but this was not included. Trials without a control treatment (e.g. dose-ranging trials) and those with a control treatment other than placebo or a TCA were excluded. In addition, trials in which all control patients received fixed doses 475 mg/day of a TCA were eliminated, as were those in which treated patients received less than 10 mg/day of fluoxetine. Within a trial, all patients were pooled according to the treatment received, irrespective of the dose received, this being equivalent to comparing a single fluoxetinetreated group with a single TCA-treated group and a single placebo-treated group. The first evidence-based diagnostic system in psychiatry is the DSM±III. Newgeneration antidepressants are indicated for major depression as defined using this diagnostic system in most countries, and this is the reason we decided to use DSM± III major depression as the only diagnostic inclusion criterion. The database contained information for 69 trials, including 6633 patients; of these, 21 trials were USA trials and 48 had been performed elsewhere (non-USA tri...
View Full Document

This note was uploaded on 01/16/2013 for the course BMS 620 taught by Professor Panavalil during the Summer '12 term at Barry Univesity.

Ask a homework question - tutors are online